Catestatin as a Biomarker of Cardiovascular Diseases: A Clinical Perspective

Catestatin as a Biomarker of Cardiovascular Diseases: A Clinical Perspective

Accounting for almost one-third of the global mortality, cardiovascular diseases (CVDs) represent a major global health issue. Emerging data suggest that most of the well-established mechanistic explanations regarding the cardiovascular pathophysiology are flawed, and cannot fully explain the progre...

Full description

Bibliographic Details
Main Authors:	Josko Bozic, Marko Kumric, Tina Ticinovic Kurir, Hrvoje Urlic, Dinko Martinovic, Marino Vilovic, Nada Tomasovic Mrcela, Josip A. Borovac
Format:	Article
Language:	English
Published:	MDPI AG 2021-11-01
Series:	Biomedicines
Subjects:	catestatin chromogranin A biomarker cardiovascular disease heart failure sympathetic nervous system
Online Access:	https://www.mdpi.com/2227-9059/9/12/1757

Similar Items

Serum Catestatin Levels Correlate with Ambulatory Blood Pressure and Indices of Arterial Stiffness in Patients with Primary Hypertension
by: Marko Kumric, et al.
Published: (2022-08-01)

The Role of Catestatin in Preeclampsia
by: Michalina Bralewska, et al.
Published: (2024-02-01)

Serum Catestatin Concentrations Are Increased in Patients with Atrial Fibrillation
by: Josip Katic, et al.
Published: (2023-02-01)

Prognostic Value of Catestatin in Severe COVID-19: An ICU-Based Study
by: Toni Kljakovic-Gaspic, et al.
Published: (2022-08-01)

Plasma Catestatin Levels and Advanced Glycation End Products in Patients on Hemodialysis
by: Mirko Luketin, et al.
Published: (2021-03-01)

The chromogranin A-derived peptides catestatin and vasostatin in dogs with myxomatous mitral valve disease
by: Katja Höglund, et al.
Published: (2020-08-01)

Catestatin: Antimicrobial Functions and Potential Therapeutics
by: Suborno Jati, et al.
Published: (2023-05-01)

Catestatin: Antimicrobial Functions and Potential Therapeutics
by: Suborno Jati, et al.
Published: (2023-05-01)

CBD supplementation reduces arterial blood pressure via modulation of the sympatho-chromaffin system: A substudy from the HYPER-H21-4 trial
by: Marko Kumric, et al.
Published: (2023-04-01)

Catestatin as a Target for Treatment of Inflammatory Diseases
by: Elke M. Muntjewerff, et al.
Published: (2018-10-01)

Catestatin—A Potential New Therapeutic Target for Women with Preeclampsia? An Analysis of Maternal Serum Catestatin Levels in Preeclamptic Pregnancies
by: Pilar Palmrich, et al.
Published: (2023-09-01)

Assessment of plasma Catestatin in COVID-19 reveals a hitherto unknown inflammatory activity with impact on morbidity-mortality
by: Francis Schneider, et al.
Published: (2022-09-01)

Erratum: Assessment of plasma Catestatin in COVID-19 reveals a hitherto unknown inflammatory activity with impact on morbidity-mortality
by: Frontiers Production Office
Published: (2022-12-01)

Chromogranin A: An Endocrine Factor of Pregnancy
by: Michalina Bralewska, et al.
Published: (2023-03-01)

The surging role of Chromogranin A in cardiovascular homeostasis
by: BRUNO eTOTA, et al.
Published: (2014-08-01)

Catestatin improves insulin sensitivity by attenuating endoplasmic reticulum stress: In vivo and in silico validation
by: Abhijit Dasgupta, et al.
Published: (2020-01-01)

Role of Echocardiography in Diabetic Cardiomyopathy: From Mechanisms to Clinical Practice
by: Hrvoje Urlic, et al.
Published: (2023-01-01)

Reduction in CgA-Derived CST Protein Level in HTR-8/SVneo and BeWo Trophoblastic Cell Lines Caused by the Preeclamptic Environment
by: Michalina Bralewska, et al.
Published: (2023-04-01)

The Emerging Roles of Chromogranins and Derived Polypeptides in Atherosclerosis, Diabetes, and Coronary Heart Disease
by: Takuya Watanabe
Published: (2021-06-01)

Role of Adropin in Cardiometabolic Disorders: From Pathophysiological Mechanisms to Therapeutic Target
by: Josko Bozic, et al.
Published: (2021-10-01)

CATESTATIN AS A NOVEL MARKER OF CARDIOVASCULAR RISK IN SYSTEMIC HYPERTENSION
by: E. Yu. Gubareva, et al.
Published: (2018-05-01)

Circulating Biomarkers Reflecting Destabilization Mechanisms of Coronary Artery Plaques: Are We Looking for the Impossible?
by: Marko Kumric, et al.
Published: (2021-06-01)

Can Fasting Curb the Metabolic Syndrome Epidemic?
by: Josip Vrdoljak, et al.
Published: (2022-01-01)

Reactivation of Intestinal Inflammation Is Suppressed by Catestatin in a Murine Model of Colitis via M1 Macrophages and Not the Gut Microbiota
by: Mohammad F. Rabbi, et al.
Published: (2017-08-01)

Effects of Wine Components in Inflammatory Bowel Diseases
by: Josip Vrdoljak, et al.
Published: (2021-09-01)

Chromogranin A and Its Fragments in the Critically Ill: An Expanding Domain of Interest for Better Care
by: Francis Schneider, et al.
Published: (2022-10-01)

Gut microbial DNA and immune checkpoint gene Vsig4/CRIg are key antagonistic players in healthy aging and age-associated development of hypertension and diabetes
by: Matthew A. Liu, et al.
Published: (2022-11-01)

THE ROLE OF CATESTATIN IN THE REGULATION OF METABOLIC DISORDERS. Review
by: O.A. Pankova
Published: (2022-06-01)

Catestanin – a promising biological marker for heart failure: A review
by: Amina M. Alieva, et al.
Published: (2022-12-01)

Association of Dephosphorylated-Uncarboxylated Matrix Gla Protein and Risk of Major Bleeding in Patients Presenting with Acute Myocardial Infarction
by: Admira Bilalic, et al.
Published: (2021-07-01)

Circulating sST2 and catestatin levels in patients with acute worsening of heart failure: a report from the CATSTAT‐HF study
by: Josip A. Borovac, et al.
Published: (2020-10-01)

The Catestatin-Derived Peptides Are New Actors to Fight the Development of Oral Candidosis
by: Davide Mancino, et al.
Published: (2022-02-01)

Catestatin in diagnosing cardiovascular and metabolic disorders in patients with comorbid hypertension
by: I.P. Dunaieva, et al.
Published: (2023-06-01)

Plasma catestatin importance and correlation in patients with dipper and non-dipper hypertension patients
by: Dursun Topal, et al.
Published: (2022-12-01)

Role of Catestatin in the Cardiovascular System and Metabolic Disorders
by: Ewa Zalewska, et al.
Published: (2022-05-01)

Clinical Implications of Uric Acid in Heart Failure: A Comprehensive Review
by: Marko Kumrić, et al.
Published: (2021-01-01)

The Role of Natural Killer (NK) Cells in Acute Coronary Syndrome: A Comprehensive Review
by: Marko Kumrić, et al.
Published: (2020-11-01)

Effects of Olive Oil and Its Components on Intestinal Inflammation and Inflammatory Bowel Disease
by: Josip Vrdoljak, et al.
Published: (2022-02-01)

Role of catestatin in development and decompensation of heart failure: a literature review
by: Yu. V. Meshcheryakov, et al.
Published: (2021-10-01)

Emerging Therapies for the Treatment of Atherosclerotic Cardiovascular Disease: From Bench to Bedside
by: Marko Kumric, et al.
Published: (2023-04-01)